[1] |
Wollensak G. Crosslinking treatment of progressive keratoconus: new hope[J]. Curr Opin Ophthalmol,2006,17(4):356-360.
|
[2] |
Spoerl E, Mrochen M, Sliney D, et al. Safety of UVA-riboflavin cross-linking of the cornea[J]. Cornea,2007,26(4):385-389.
|
[3] |
Wollensak G, Wilsch M, Spoerl E, et al. Collagen fiber diameter in the rabbit cornea after collagen crosslinking by riboflavin/UVA[J]. Cornea,2004,23(5):503-507.
|
[4] |
Baiocchi S, Mazzotta C, Cerretani D, et al. Corneal crosslinking: riboflavin concentration in corneal stroma exposed with and without epithelium[J]. J Cataract Refract Surg,2009,35(5):893-899.
|
[5] |
庞旭,彭秀军. 紫外光/核黄素角膜交联术后并发症及防治的研究进展[J]. 中国医师进修杂志,2013,36(9):73-76.
|
[6] |
Kymionis GD, Portaliou DM, Diakonis VF, et al. Corneal collagen cross-linking with riboflavin and ultraviolet-A irradiation in patients with thin corneas[J]. Am J Ophthalmol,2012,153(1):24-28.
|
[7] |
Bottos KM, Dreyfuss JL, Regatieri CV, et al. Immunofluorescence confocal microscopy of porcine corneas following collagen cross-linking treatment with riboflavin and ultraviolet A[J]. J Refract Surg,2008,24(7):S715-S719.
|
[8] |
Bottós KM, Schor P, Dreyfuss JL, et al. Effect of corneal epithelium on ultraviolet-A and riboflavin absorption[J]. Arq Bras Oftalmol, 2011,74(5):348-351.
|
[9] |
Hayes S, O′Brart DP, Lamdin LS, et al. Effect of complete epithelial debridement before riboflavin-ultraviolet-A corneal collagen crosslinking therapy[J]. J Cataract Refract Surg,2008, 34(4):657-661.
|
[10] |
Samaras K, O′Brart DP, Doutch J, et al. Effect of epithelial retention and removal on riboflavin absorption in porcine corneas[J]. J Refract Surg,2009,25(9):771-775.
|
[11] |
Yuen L, Chan C, Boxer Wachler BS. Effect of epithelial debridement in corneal collagen crosslinking therapy in porcine and human eyes[J]. J Cataract Refract Surg,2008,34(11):1815-1816.
|
[12] |
Wollensak G, Iomdina E. Biomechanical and histological changes after corneal crosslinking with and without epithelial debridement[J]. J Cataract Refract Surg,2009,35(3):540-546.
|
[13] |
Koppen C, Wouters K, Mathysen D, et al. Refractive and topographic results of benzalkonium chloride-assisted transepithelial crosslinking[J]. J Cataract Refract Surg,2012,38(6):1000-1005.
|
[14] |
Kissner A, Spoerl E, Jung R, et al. Pharmacological modification of the epithelial permeability by benzalkonium chloride in UVA/Riboflavin corneal collagen cross-linking[J]. Curr Eye Res, 2010,35(8):715-721.
|
[15] |
伍腾飞. HPLC 法测定兔角膜基质中核黄素含量的实验研究[D]. 合肥:安徽医科大学,2013.
|
[16] |
Leccisotti A, Islam T. Transepithelial corneal collagen cross-linking in keratoconus[J]. J Refract Surg,2010,26(12):942-948.
|
[17] |
Filippello M, Stagni E, O′Brart D. Transepithelial corneal collagen crosslinking: bilateral study[J]. J Cataract Refract Surg, 2012,38(2):283-291.
|
[18] |
Spoerl E, Hoyer A, Pillunat LE, et al. Corneal cross-linking and safety issues[J]. Open Ophthalmol J,2011,5:14-16.
|
[19] |
Boxer WB, Pinelli R, Ertan A, et al. Safety and efficacy of transepithelial crosslinking (C3-R/CXL)[J]. J Cataract Refract Surg,2010,36(1):186-189.
|
[20] |
Scarcelli G, Kling S, Quijano E, et al. Brillouin microscopy of collagen crosslinking: noncontact depth-dependent analysis of corneal elastic modulus[J]. Invest Ophthalmol Vis Sci,2013,54(2):1418-1425.
|
[21] |
Meadows DL, Paugh JR, Joshi A, et al. A novel method to evaluate residence time in humans using a nonpenetrating fluorescent tracer[J]. Invest Ophthalmol Vis Sci,2002,43(4):1032-1039.
|
[22] |
Raiskup F, Spoerl E. Corneal cross-linking with hypo-osmolar riboflavin solution in thin keratoconic corneas[J]. Am J Ophthalmol,2011,152(1):28-32.
|
[23] |
Rosetta P, Vinciguerra R, Romano MR, et al. Corneal collagen cross-linking window absorption[J]. Cornea,2013,32(4):550-554.
|
[24] |
Raiskup F, Pinelli R, Spoerl E. Riboflavin osmolar modification for transepithelial corneal cross-linking[J]. Curr Eye Res,2012, 37(3):234-238.
|
[25] |
Wollensak G, Aurich H, Wirbelauer C, et al. Significance of the riboflavin film in corneal collagen crosslinking[J]. J Cataract Refr Surg,2010,36(1):114-120.
|
[26] |
Hayes S, Boote C, Kamma-Lorger CS, et al. Riboflavin/UVA collagen cross-linking-induced changes in normal and keratoconus corneal stroma[J]. PLoS One,2011,6(8):e22405.
|
[27] |
Hafezi F. Limitation of collagen cross-linking with hypoosmolar riboflavin solution: failure in an extremely thin cornea[J]. Cornea,2011,30(8):917-919.
|
[28] |
金男. 经上皮角膜胶原交联术治疗圆锥角膜的安全性、有效性研究[D]. 温州:温州医学院,2013.
|
[29] |
Schumacher S, Mrochen M, Wernli J, et al. Optimization model for UV-riboflavin corneal cross-linking[J]. Invest Ophthalmol Vis Sci,2012,53(2):762-769.
|
[30] |
Dong Z, Zhou X. Collagen cross-linking with riboflavin in a femtosecond laser-created pocket in rabbit corneas: 6-month results[J]. Am J Ophthalmol,2011,152(1):22-27.
|
[31] |
Alio JL, Toffaha BT, Pinero DP, et al. Cross-linking in progressive keratoconus using an epithelial debridement or intrastromal pocket technique after previous corneal ring segment implantation[J]. J Refract Surg,2011,27(10):737-743.
|
[32] |
樊郑军. 应用离子导入法的核黄素紫外线角膜交联治疗1例[J]. 海军总医院学报,2010,23(3):191-192.
|
[33] |
原越,张少斌,刘玉强,等. 跨上皮离子导入角膜胶原交联治疗玻璃体切割手术后角膜上皮迁延不愈一例[J]. 中华眼底病杂志,2014,30(2):207-208.
|
[34] |
Stewart JM, Lee OT, Wong FF, et al. Cross-linking with ultraviolet-a and riboflavin reduces corneal permeability[J]. Invest Ophthalmol Vis Sci,2011,52(12):9275-9278.
|
[35] |
Tschopp M, Stary J, Frueh BE, et al. Impact of corneal cross-linking on drug penetration in an ex vivo porcine eye model[J]. Cornea,2012,31(3):222-226.
|
[36] |
Wollensak G, Spoerl E. Collagen crosslinking of human and porcine sclera[J]. J Cataract Refract Surg,2004,30(3):689-695.
|
[37] |
Iseli HP, Spoerl E, Wiedemann P, et al. Efficacy and safety of blue-light scleral cross-linking[J]. J Refract Surg,2008,24(7):S752-S755.
|
[38] |
Ambati J, Canakis CS, Miller JW, et al. Diffusion of high molecular weight compounds through sclera[J]. Invest Ophth Vis Sci,2000,41(5):1181-1185.
|
[39] |
Cruysberg LPJ, Nuijts RMMA, Geroski DH, et al. The influence of intraocular pressure on the transscleral diffusion of high-molecular-weight compounds[J]. Invest Ophthalmol Vis Sci,2005,46(10):3790-3794.
|
[40] |
Nicoli S, Ferrari G, Quarta M, et al. Porcine sclera as a model of human sclera for in vitro transport experiments: histology, SEM, and comparative permeability[J]. Mol Vis,2009,15:259-266.
|
[41] |
Wollensak G, Iomdina E. Long-term biomechanical properties of rabbit sclera after collagen crosslinking using riboflavin and ultraviolet A (UVA)[J]. Acta Ophthalmol,2009,87(2):193-198.
|
[42] |
Miao H, Wu BD, Tao Y, et al. Diffusion of macromolecules through sclera[J]. Acta Ophthalmol,2013,91(1):e1-e6.
|
[43] |
Choi S, Lee SC, Lee HJ, et al. Structural response of human corneal and scleral tissues to collagen cross-linking treatment with riboflavin and ultraviolet A light[J]. Laser Med Sci,2013, 28(5):1289-1296.
|
[44] |
Zhang YL, Li ZW, Liu L, et al. Comparison of riboflavin/ultraviolet-A cross-linking in porcine, rabbit, and human sclera[J]. Biomed Res Int,2014,2014:194204.
|
[45] |
Wang MM, Zhang FJ, Qian XQ, et al. Regional Biomechanical properties of human sclera after cross-linking by riboflavin/ultraviolet A[J]. J Refract Surg,2012,28(10):723-728.
|
[46] |
Stewart JM, Schultz DS, Lee OT, et al. Exogenous collagen cross-linking reduces scleral permeability: modeling the effects of age-related cross-link accumulation[J]. Invest Ophthalmol Vis Sci,2009,50(1):352-357.
|
[47] |
张亚丽. 巩膜核黄素/紫外线A胶原交联的实验研究[D]. 济南:山东大学医学院,2013.
|
[48] |
Ziak L, Májek P, Hroboňová K, et al. Simultaneous determination of caffeine, caramel and riboflavin in cola-type and energy drinks by synchronous fluorescence technique coupled with partial least squares[J]. Food Chem,2014,159:282-286.
|
[49] |
Kampik D, Ralla B, Keller S, et al. Influence of corneal collagen crosslinking with riboflavin and ultraviolet-a irradiation on excimer laser surgery[J]. Invest Ophthalmol Vis Sci,2010,51(8):3929-3934.
|